1. Home
  2. GDHG vs THAR Comparison

GDHG vs THAR Comparison

Compare GDHG & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDHG
  • THAR
  • Stock Information
  • Founded
  • GDHG 2008
  • THAR 2017
  • Country
  • GDHG China
  • THAR United States
  • Employees
  • GDHG N/A
  • THAR N/A
  • Industry
  • GDHG Services-Misc. Amusement & Recreation
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDHG Consumer Discretionary
  • THAR Health Care
  • Exchange
  • GDHG Nasdaq
  • THAR Nasdaq
  • Market Cap
  • GDHG 19.4M
  • THAR 22.8M
  • IPO Year
  • GDHG 2023
  • THAR 2022
  • Fundamental
  • Price
  • GDHG $4.28
  • THAR $3.00
  • Analyst Decision
  • GDHG
  • THAR Strong Buy
  • Analyst Count
  • GDHG 0
  • THAR 1
  • Target Price
  • GDHG N/A
  • THAR $17.00
  • AVG Volume (30 Days)
  • GDHG 53.3K
  • THAR 3.4M
  • Earning Date
  • GDHG 07-11-2025
  • THAR 11-07-2025
  • Dividend Yield
  • GDHG N/A
  • THAR N/A
  • EPS Growth
  • GDHG N/A
  • THAR N/A
  • EPS
  • GDHG N/A
  • THAR N/A
  • Revenue
  • GDHG $16,666,899.00
  • THAR N/A
  • Revenue This Year
  • GDHG N/A
  • THAR N/A
  • Revenue Next Year
  • GDHG N/A
  • THAR N/A
  • P/E Ratio
  • GDHG N/A
  • THAR N/A
  • Revenue Growth
  • GDHG N/A
  • THAR N/A
  • 52 Week Low
  • GDHG $2.40
  • THAR $0.95
  • 52 Week High
  • GDHG $1,968.41
  • THAR $9.08
  • Technical
  • Relative Strength Index (RSI)
  • GDHG 40.65
  • THAR 45.30
  • Support Level
  • GDHG $3.96
  • THAR $2.85
  • Resistance Level
  • GDHG $4.25
  • THAR $5.27
  • Average True Range (ATR)
  • GDHG 0.28
  • THAR 0.75
  • MACD
  • GDHG 0.07
  • THAR -0.01
  • Stochastic Oscillator
  • GDHG 50.31
  • THAR 4.42

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: